AstraZeneca anticipates a 2026 support of “mid-high single-digit sales development”.
发布者:BY MARKETWIRE,转转请注明出处:https://robotalks.cn/astrazeneca-expects-robust-2026-led-by-strong-cancer-drug-demand/
AstraZeneca anticipates a 2026 support of “mid-high single-digit sales development”.
发布者:BY MARKETWIRE,转转请注明出处:https://robotalks.cn/astrazeneca-expects-robust-2026-led-by-strong-cancer-drug-demand/